Literature DB >> 9268154

The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity.

C C Smith1, L Aurelian.   

Abstract

The large subunit of herpes simplex virus type 2 (HSV-2) ribonucleotide reductase (ICP10) was identified in sucrose gradient-purified HSV-2 virions by immunoprecipitation/immunoblotting with antibody specific for the protein kinase (PK) domain. Immunoblotting of individual gradient fractions indicated that ICP10 cosediments with the major capsid protein and the highest virus titers. ICP10 was not labeled by iodination of purified virions, indicating that it is not located on the virion surface. After envelope glycoproteins were removed by detergent treatment, ICP10 was associated with capsid-tegument particles and became sensitive to trypsin digestion. The capsid-tegument-associated ICP10 was phosphorylated and had PK activity in vitro and on Immobilon membranes. A mutant ICP10 protein deleted in the PK domain (p95) was also associated with purified virions (ICP10deltaPK virus) but it lacked PK activity. The data indicate that ICP10 is contained within the tegument component where it retains intrinsic PK activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268154     DOI: 10.1006/viro.1997.8645

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity.

Authors:  Christopher B Whitehurst; Shunbin Ning; Gretchen L Bentz; Florent Dufour; Edward Gershburg; Julia Shackelford; Yves Langelier; Joseph S Pagano
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

2.  The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity.

Authors:  Erin K Golembewski; Samantha Q Wales; Laure Aurelian; Paul J Yarowsky
Journal:  Exp Neurol       Date:  2006-10-16       Impact factor: 5.330

3.  A single viral gene determines lethal cross-species neurovirulence of baboon herpesvirus HVP2.

Authors:  Darla Black; Kazutaka Ohsawa; Shaun Tyler; Lara Maxwell; R Eberle
Journal:  Virology       Date:  2014-01-29       Impact factor: 3.616

4.  Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

Authors:  Jennifer M Laing; Michael D Gober; Erin K Golembewski; Scott M Thompson; Kymberly A Gyure; Paul J Yarowsky; Laure Aurelian
Journal:  Mol Ther       Date:  2006-02-24       Impact factor: 11.454

5.  Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.

Authors:  C C Smith; J Nelson; L Aurelian; M Gober; B B Goswami
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.

Authors:  D Perkins; E F R Pereira; M Gober; P J Yarowsky; L Aurelian
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures.

Authors:  Kerstin Radtke; Daniela Kieneke; André Wolfstein; Kathrin Michael; Walter Steffen; Tim Scholz; Axel Karger; Beate Sodeik
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

8.  The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.

Authors:  C C Smith; T Peng; M Kulka; L Aurelian
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

9.  The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

Authors:  A G Colunga; J M Laing; L Aurelian
Journal:  Gene Ther       Date:  2009-10-01       Impact factor: 5.250

Review 10.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.